NovoCure Limited (NASDAQ:NVCR) Q3 2023 Earnings Call Transcript October 26, 2023 NovoCure Limited beats earnings expectations. Reported EPS is $-0.46, expectations were $-0.52. Operator: Welcome to the NovoCure Q3 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your […]
NovoCure Limited (NASDAQ:NVCR – Get Free Report) shares rose 7.2% during mid-day trading on Monday . The stock traded as high as $15.24 and last traded at $15.24. Approximately 445,283 shares were traded during mid-day trading, a decline of 68% from the average daily volume of 1,394,237 shares. The stock had previously closed at $14.21. […]
NovoCure Limited (NASDAQ:NVCR – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 7,580,000 shares, a drop of 17.7% from the August 31st total of 9,210,000 shares. Based on an average daily trading volume, of 1,760,000 shares, the short-interest ratio […]
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. The […]